137 related articles for article (PubMed ID: 11120051)
1. CTLA-4IG treatment induces long-term acceptance of rat small bowel allografts.
Tarumi K; Yagihashi A; Tsuruma T; Araya J; Hirata K
Transplant Proc; 2000 Nov; 32(7):2028-31. PubMed ID: 11120051
[No Abstract] [Full Text] [Related]
2. Induction and maintenance of tolerance by CTLA-4IG in rat small bowel allografts.
Tarumi K; Yagihashi A; Tsuruma T; Koide S; Sasaki K; Hirata K
Transplant Proc; 1999; 31(1-2):878-81. PubMed ID: 10083385
[No Abstract] [Full Text] [Related]
3. Prolongation of rat small bowel allograft survival by CTLA-4 IG.
Tarumi K; Yagihashi A; Murakami M; Uede T; Hirata K
Transplant Proc; 1998 Sep; 30(6):2596-9. PubMed ID: 9745507
[No Abstract] [Full Text] [Related]
4. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts.
Tarumi K; Murakami M; Yagihashi A; Nakagawa I; Hirata K; Uede T
Transplantation; 1999 Feb; 67(4):520-5. PubMed ID: 10071020
[TBL] [Abstract][Full Text] [Related]
5. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
6. CD28-pathway blockade with CTLA4Ig leads to prolongation of small bowel transplant survival in rats.
Pescovitz MD; Yang R; Liu Q; Collins MH; Grosfeld JL
Transplant Proc; 1994 Jun; 26(3):1618-9. PubMed ID: 8030059
[No Abstract] [Full Text] [Related]
7. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
Greenstein SM; Sun S; Schechner RS; Tellis VA
Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
[No Abstract] [Full Text] [Related]
8. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig.
Yin DP; Sankary HN; Williams J; Krieger N; Fathman CG
Transplantation; 1996 Dec; 62(11):1537-9. PubMed ID: 8970603
[TBL] [Abstract][Full Text] [Related]
9. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2.
Arima T; Rehman A; Flye MW
Transplant Proc; 1997; 29(1-2):1305-6. PubMed ID: 9123318
[No Abstract] [Full Text] [Related]
10. Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts.
Onodera K; Chandraker A; Korom S; Stadlbauer TH; Kato K; Kasai S; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1998 Feb; 30(1):16-8. PubMed ID: 9474943
[No Abstract] [Full Text] [Related]
11. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Nogimura H; Ohi S; Kageyama Y; Matsushita K; Ito Y; Takahashi T; Suzuki K; Suzuki S; Kazui T
Transplant Proc; 2000 Nov; 32(7):2036-7. PubMed ID: 11120055
[No Abstract] [Full Text] [Related]
12. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
[TBL] [Abstract][Full Text] [Related]
13. CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis.
Li W; Lu L; Wang Z; Wang L; Thomson A; Fung J; Qian S
Transplant Proc; 2001; 33(1-2):246-7. PubMed ID: 11266801
[No Abstract] [Full Text] [Related]
14. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
[TBL] [Abstract][Full Text] [Related]
15. Pattern of alloimmune response in second same donor allografts after induction of tolerance using CTLA4Ig.
Olthoff KM; Gelman AE; Zamir GA; Debonera F; Krasinkas AM; Shen X; Gao F; Shaked A
Transplantation; 2001 Dec; 72(12):1952-6. PubMed ID: 11773895
[TBL] [Abstract][Full Text] [Related]
16. Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.
Ferrari-Lacraz S; Zheng XX; Kim YS; Maslinski W; Strom TB
Transplant Proc; 2002 May; 34(3):745-7. PubMed ID: 12034169
[No Abstract] [Full Text] [Related]
17. Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
Tice DG; Bruch D; Ikramuddin S
Transplant Proc; 1996 Oct; 28(5):2496. PubMed ID: 8907920
[No Abstract] [Full Text] [Related]
18. CTLA4Ig inhibits alloantibody responses to transfusions and transplants.
Ibrahim S; Jakobs F; Linsley PS; Sanfilippo F; Baldwin WM
Transplant Proc; 1997; 29(1-2):1025. PubMed ID: 9123179
[No Abstract] [Full Text] [Related]
19. Effectiveness of adenovirus-mediated gene transfer with CTLA4Ig in allo and xeno-transplantation.
Hayashi S; Dai-Kaku L; Namii Y; Kato T; Tokoro T; Kobayashi T; Yokoyama I; Hamada H; Nakao A
Transplant Proc; 2000 Nov; 32(7):2520-1. PubMed ID: 11120276
[No Abstract] [Full Text] [Related]
20. Gene gun-mediated CTLA4Ig-gene transfer for modification of allogeneic cardiac grafts.
Umeda Y; Iwata H; Yoshikawa S; Matsuno Y; Marui T; Nitta T; Idia Y; Takagi H; Mori Y; Miyazaki J; Kosugi A; Hirose H
Transplant Proc; 2002 Nov; 34(7):2622-3. PubMed ID: 12431548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
